Failure to vaccinate newborns with the Bacillus Calmette-Guérin (BCG) vaccine puts them at serious risk of developing ...

Bacille Calmette-Guérin revaccination shows no efficacy in preventing sustained Mycobacterium tuberculosis infection compared with placebo in adolescents in a phase 2b study.

New global study shows childhood vaccine coverage stalled by COVID-19, with urgent need to boost immunisation by 2030 to meet WHO targets.

A new study has cast a sobering light on Uganda’s immunization efforts, revealing alarmingly high levels of vaccine wastage ...

The five-year, 150-person, phase 2 trial is investigating whether repeat BCG vaccination can clinically improve type 1 diabetes in adults with existing disease and is almost fully enrolled.

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

MPs launch probe into polio, BCG vaccine distribution across the country The probe follows a nationwide shortage that has raised alarm among health professionals and lawmakers.

The Bacille Calmette–Guérin (BCG) vaccine, originally developed for tuberculosis prevention, has garnered considerable attention for its capacity to reprogramme the innate immune system. Beyond ...

The story of tuberculosis goes back to the start of recorded human history, and since the 1800s it’s estimated it has been responsible for over 1 billion deaths. In New Zealand today we don’t have ...

BCG does not make leprosy an immunopreventable disease, in the sense that the disease cannot be controlled with the BCG vaccine alone; other measures are required, but in the light of the present ...

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...

While tuberculosis is not a major health issue in New Zealand, worldwide it remains the leading infectious disease killer.  ...